Al Ahly Pharos

Pre-Session Views

Al Ahly Pharos
  • Strategy| Market intelligence - Launch of Ras El Hekma should unlock IMF funding and inflate ORAS and ELEC valuations
  • RMDA| Acquisition of high-margin chronic disease molecule reinforces strategic outlook and FY25 targets
  • BONY| Discounted entry and an above average rent yield — but dividend void and cashflow thinness limit appeal
  • ETEL| 12M rally = cost of equity
  • GBCO| Another management call confirms our positive view on the stock; Margins hold firm amid regional challenges, GB Capital beats, incentives to boost 2H25 earnings
  • EGAL| Hold EGAL to EGP200/share